Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

OMIC
Singular Genomics Systems, Inc. Common Stock
stock NASDAQ

Inactive
Feb 20, 2025
20.01USD+0.251%(+0.05)7,916
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-19.96)0
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 10, 2022
07:44AM EST  Singular Genomics Partners With Lexogen To 'Enable RNA Library Prep for the G4 Sequencing Platform'   Benzinga
07:43AM EST  Singular Genomics Partners With Dovetail Genomics To 'Enable Dovetail Kits for the G4 Sequencing Platform'   Benzinga
07:42AM EST  Singular Genomics Partners With Watchmaker Genomics To Enable Watchmaker DNA Library Prep Kits For The G4 Sequencing Platform   Benzinga
07:30AM EST  Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with New England Biolabs (NEB) to validate its NEBNext kits, a product line for both DNA and RNA sample prep, with the G4 sequencing platform.   GlobeNewswire Inc
07:30AM EST  Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Twist Bioscience to validate its NGS Target Enrichment Solutions, high-quality target enrichment panels either curated or custom, with the G4 sequencing platform.   GlobeNewswire Inc
07:30AM EST  Singular Genomics Partners with Dovetail Genomics to Enable   GlobeNewswire Inc
07:30AM EST  Singular Genomics Partners with Lexogen to Enable RNA Library Prep   GlobeNewswire Inc
07:30AM EST  Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Watchmaker Genomics to validate its Watchmaker DNA Library Prep Kits with Fragmentation for the G4 sequencing platform.   GlobeNewswire Inc
Jan 7, 2022
04:18PM EST  Singular Genomics G4 Launch Impresses BofA Analyst: What's Next?   Benzinga
01:04PM EST  B of A Securities Upgrades Singular Genomics Systems to Buy, Announces $21 Price Target   Benzinga
08:00AM EST  Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present virtually at the 40th Annual J.P. Morgan Healthcare Conference.   GlobeNewswire Inc
Jan 6, 2022
04:05PM EST  Singular Genomics Appoints Genomics Research Pioneer Elaine R.   GlobeNewswire Inc
07:38AM EST  Singular Genomics And Broad Institute Partner To Integrate Advanced Sequencing Technology With The Terra Data Platform   Benzinga
07:30AM EST  Singular Genomics and Broad Institute Partner to Integrate   GlobeNewswire Inc
Dec 16, 2021
07:30AM EST  Singular Genomics Launches the G4 Sequencing Platform   GlobeNewswire Inc
Nov 9, 2021
05:57PM EST  Singular Genomics Systems Q3 EPS $(0.25) Misses $(0.24) Estimate   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 28, 2021
08:18AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive   Benzinga
08:16AM EDT  The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments   Benzinga
Sep 22, 2021
07:45AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs   Benzinga
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Aug 19, 2021
10:57AM EDT  The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 5, 2021
07:30AM EDT  Singular Genomics Systems, Inc. to Present at theUBS   GlobeNewswire Inc
Aug 3, 2021
06:19AM EDT  Singular Genomics Systems Q2 EPS $(1.18) Down From $(0.65) YoY   Benzinga
06:05AM EDT  Singular Genomics Systems, Inc. Announces Second Quarter Financial   GlobeNewswire Inc
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 21, 2021
07:52AM EDT  The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
08:08AM EDT  The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs   Benzinga
Jul 14, 2021
07:48AM EDT  The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues   Benzinga
Jun 21, 2021
10:15AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021   Benzinga
09:20AM EDT  B of A Securities Initiates Coverage On Singular Genomics Systems with Neutral Rating, Announces Price Target of $26   Benzinga
07:34AM EDT  Cowen & Co. Initiates Coverage On Singular Genomics Systems with Outperform Rating   Benzinga
05:25AM EDT  JP Morgan Initiates Coverage On Singular Genomics Systems with Overweight Rating, Announces Price Target of $30   Benzinga
04:57AM EDT  Goldman Sachs Initiates Coverage On Singular Genomics Systems with Buy Rating, Announces Price Target of $35   Benzinga
Jun 16, 2021
08:20AM EDT  The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO   Benzinga
Jun 1, 2021
04:05PM EDT  Singular Genomics Systems, Inc. Announces Closing of Initial   GlobeNewswire Inc
May 27, 2021
11:52AM EDT  Singular Genomics Systems Shares Open For Trade At $29; IPO Priced $22/Share   Benzinga
10:39AM EDT  Singular Genomics Systems Shares Indicating $29.50   Benzinga
10:20AM EDT  Singular Genomics Systems Shares Indicating $22/Share   Benzinga
09:18AM EDT  Singular Genomics Systems Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced $22/Share   Benzinga
May 26, 2021
11:57PM EDT  Singular Genomics Systems, Inc. Announces Pricing of Upsized   GlobeNewswire Inc
May 24, 2021
07:03AM EDT  Omic Singular Genomics Systems Sees Currently Estimated That IPO Price Per Share Will Be Between $20-$22; Sees IPO Of 8.5M Shares Of Common Stock   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC